Ozempic (semaglutida 1 mg semanal, indicacin DM2) es probablemente el frmaco ms demandado de los ltimos 5 aos en Colombia, y tambin uno de los ms difciles de conseguir de manera consistente
Sermorelin, CJC-1295 (No-DAC) and Ipamorelin compared: half-life, GH profile, selectivity and evidence
PangSChenXLuZMengLHuangYYuXet alLongevity of centenarians is reflected by the gut microbiome with youth-associated signatures
Updated July 2026 The Ozempic and GLP-1 gastroparesis lawsuits involve claims that manufacturers of GLP-1 medications such as Ozempic, Wegovy, Mounjaro, Rybelsus, Trulicity, Zepbound, and Saxenda failed to adequately warn patients and doctors about the potential risk of developing gastroparesis (i.e., stomach paralysis or delayed gastric emptying), a serious gastrointestinal injury that can cause persistent nausea, vomiting, abdominal pain, bloating, dehydration, malnutrition, hospitalization, or the need for feeding tubes or other invasive treatment